Seroatlas · Human Serome Atlas

CELA2A

Chymotrypsin-like elastase family member 2A

Also known as: CEL2A_HUMAN, ELA2A

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P08217
Gene
CELA2A
Ensembl
ENSG00000142615
Chromosome
1
Canonical length
269 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins
Secretome location
Secreted to digestive system

OverviewNCBI Gene

Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Like most of the human elastases, elastase 2A is secreted from the pancreas as a zymogen. In other species, elastase 2A has been shown to preferentially cleave proteins after leucine, methionine, and phenylalanine residues. [provided by RefSeq, May 2009]

Canonical amino-acid sequenceUniProt

269 residues, UniProt reviewed canonical sequence.

>P08217|CELA2A
     1  MIRTLLLSTL VAGALSCGDP TYPPYVTRVV GGEEARPNSW PWQVSLQYSS NGKWYHTCGG
    61  SLIANSWVLT AAHCISSSRT YRVGLGRHNL YVAESGSLAV SVSKIVVHKD WNSNQISKGN
   121  DIALLKLANP VSLTDKIQLA CLPPAGTILP NNYPCYVTGW GRLQTNGAVP DVLQQGRLLV
   181  VDYATCSSSA WWGSSVKTSM ICAGGDGVIS SCNGDSGGPL NCQASDGRWQ VHGIVSFGSR
   241  LGCNYYHKPS VFTRVSNYID WINSVIANN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CELA2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
153,460 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 153,460 nTPM
  • ovary: 28 nTPM
  • salivary gland: 26 nTPM
  • heart muscle: 25 nTPM
  • duodenum: 17 nTPM
  • stomach: 15 nTPM

Single-cell type

  • pancreatic acinar cells: 1,882 nCPM
  • pancreatic duct cells: 15 nCPM
  • epicardial cells: 9.1 nCPM
  • basal keratinocytes: 4.9 nCPM
  • monocytes: 3.7 nCPM
  • endometrial luminal cells: 3.1 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebellum: 1.1 nTPM
  • cerebral cortex: 0.9 nTPM
  • basal ganglia: 0.8 nTPM
  • midbrain: 0.6 nTPM
  • thalamus: 0.6 nTPM
  • hippocampal formation: 0.5 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CELA2A.

Disease | AllUniProt

Conditions CELA2A is implicated in, by any mechanism.

Disease | GeneticClinVar

5 pathogenic / likely-pathogenic of 56 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.83
gnomAD pLI
0
gnomAD missense Z
0.04
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CELA2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CELA2A as an antibody target. Whether an autoantibody or antibody against CELA2A could matter depends on whether native CELA2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CELA2A is annotated as secreted, so native CELA2A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CELA2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CELA2A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...